false
Catalog
2024 World Conference on Lung Cancer (WCLC) - Post ...
P2.17A.08 Trends in Pulmonary Embolism Outcomes Am ...
P2.17A.08 Trends in Pulmonary Embolism Outcomes Among Lung Cancer Patients: A Nationwide Analysis Across a Decade
Back to course
Pdf Summary
The study analyzes trends in pulmonary embolism (PE) outcomes among lung cancer (LC) patients over a decade using the National Inpatient Sample data from 2012 to 2021. Lung cancer is a prevalent cancer in the U.S. and a significant cause of cancer-related deaths, with PE contributing to 10% mortality within LC patients. The research aims to evaluate whether current guidelines are effective and identify potential improvements.<br /><br />Key findings indicate that while the total hospital admissions for PE increased from 179,615 to 197,115, the percentage of LC patients admitted with PE decreased from 3.8% to 3.4%. Despite the decline in PE incidence among LC patients, their mortality rates have been rising, with decreasing usage of surgical interventions. Surgical interventions are typically reserved for high-risk PE cases. <br /><br />The study also reveals that PE patients with LC experienced longer hospital stays than those without LC, although the duration has declined over the years, from 5.7 days versus 5.1 days in 2012 to 5.1 days versus 4.4 days in 2021. Hospitalization costs for PE patients with LC rose from $53,588 to $61,441 from 2012 to 2021, with a similar increase for non-LC PE patients after inflation adjustments.<br /><br />The research concludes that despite a reduction in PE incidence among LC patients, increasing mortality rates coupled with higher healthcare utilization, and decreased surgical interventions suggest the need to reassess treatment guidelines. It emphasizes the importance of reviewing thromboprophylaxis protocols tailored for LC patients with PE to potentially reduce morbidity and mortality.
Asset Subtitle
Divya Solipuram
Meta Tag
Speaker
Divya Solipuram
Topic
Global Health, Health Services & Health Economics
Keywords
pulmonary embolism
lung cancer
mortality rates
National Inpatient Sample
surgical interventions
hospitalization costs
thromboprophylaxis protocols
healthcare utilization
treatment guidelines
cancer-related deaths
×
Please select your language
1
English